Richard A. Larson to Catalytic Domain
This is a "connection" page, showing publications Richard A. Larson has written about Catalytic Domain.
Connection Strength
0.029
-
BCR-ABL1 compound mutations combining key kinase domain positions confer clinical resistance to ponatinib in Ph chromosome-positive leukemia. Cancer Cell. 2014 Sep 08; 26(3):428-442.
Score: 0.029